Gabapentin enacarbil Completed Phase 3 Trials for Restless Legs Syndrome (RLS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00748098Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance
NCT00298623XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.
NCT00311363Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.
NCT00333359XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.
NCT00365352XP13512 vs. Placebo in Patients With Restless Legs Syndrome.
NCT02658188Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients